However, grade ≥ 3 AEs were more frequent in patients treated with angiogenesis inhibitors and included hypertension, hemorrhage and proteinuria for anti-angiogenic-induced events, and neutropenia, thrombocytopenia, diarrhea and fatigue for EGFR-TKIs induced events. This evidence concerns the gene EGFR and Thrombocytopenia.